CONTRACT KICKOFF MEETING AND PROJECT MANAGEMENT PLAN
合同启动会议和项目管理计划
基本信息
- 批准号:10721055
- 负责人:
- 金额:$ 1.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAnimal Disease ModelsAnimalsBiological ProductsBiological Response Modifier TherapyBiomedical ResearchChemistryClinical ResearchClinical TrialsComplexContractsDevelopmentDocumentationDoseEvaluationExtramural ActivitiesHelping to End Addiction Long-termHuman ResourcesIn VitroLaboratoriesMetabolismModelingNational Institute of Neurological Disorders and StrokeNeonatalNeurological ModelsPainPatientsPluripotent Stem CellsProcessProgram DevelopmentReportingResearchResearch ActivityServicesTechnology TransferTestingTissuesToxicologyUnited States National Institutes of HealthValidationabsorptioncarcinogenicitydrug developmentdrug discoveryefficacy testingexperiencegene therapyin vivomanufacturing process developmentmanufacturing scale-upmeetingsnervous system disorderpharmacokinetics and pharmacodynamicsprogramsreproductiveresearch and developmentresearch facilitystability testingtherapeutic development
项目摘要
The purpose of this requirement is to acquire complex, specialized and strategic services to support National Institutes of Health (NIH) activities. The NIH requires a research organization to support the NIH biologics development projects for the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the National Institute of Neurological Disorders and Stroke (NINDS) Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP ), as well as other extramural or intramural NIH drug discovery and development programs. This requires highly qualified and experienced personnel capable of providing a full range of specialized, strategic, technical and operational services to deliver the support that is critical to the broad range of NIH biomedical and clinical research activities in-process, planned and unanticipated.
The objective of this contract is to support the BPN-Biologics, URGenT, HEAL-PTDP and other NIH programs by providing:
A. Manufacturing services including, but not limited to:
(1) Technology-transfer of an R&D laboratory scale process from a research facility to the contract manufacturing organization (CMO)
(2) Biological therapeutics manufacturing process development
(3) Chemistry, manufacturing, and controls (CMC) development
(4) Small-scale manufacture, scale-up, and manufacturing under current Good Manufacturing Practice (cGMP)
(5) Fill-finish, release testing, validation, stability testing, and other associated tasks
(6) CMC study report documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for these NIH programs
B. Nonclinical services including, but not limited to:
(1) Efficacy testing in in vitro, in vivo or ex vivo models, including modeling neurological disease using patient derived pluripotent stem cells, or in animal models of disease, or in naïve animals, or in ex vivo tissue or small explant cultures
(2) Absorption, distribution, metabolism, and elimination (ADME) studies
(3) Pharmacokinetic (PK) and pharmacodynamic (PD) characterization
(4) Toxicology studies including, but not limited to single-dose and/or repeat dose toxicology studies, and/or reproductive toxicology and/or carcinogenicity studies, and/or neonatal and juvenile toxicology studies
(5) Nonclinical study report and documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for these NIH programs.
这一要求的目的是获得复杂的,专业的和战略性的服务,以支持美国国立卫生研究院(NIH)的活动。NIH需要一个研究组织来支持NIH蓝图神经治疗网络生物制剂的NIH生物制剂开发项目(BPN-Biologics)计划,国家神经疾病和中风研究所(NINDS)超罕见基因治疗(URGenT)计划,帮助结束成瘾长期疼痛治疗开发计划(HEAL-PTDP),以及其他校外或校内NIH药物发现和开发计划。这需要高素质和经验丰富的人员能够提供全方位的专业,战略,技术和业务服务,以提供支持,这是至关重要的广泛的NIH生物医学和临床研究活动的过程中,计划和意外。
本合同的目的是通过提供以下服务来支持BPN-Biologics、URGenT、HEAL-PTDP和其他NIH项目:
A. 制造服务包括但不限于:
(一) 从研究机构到合同生产组织(CMO)的研发实验室规模工艺的技术转移
(二) 生物治疗剂生产工艺开发
(三) 化学、生产和控制(CMC)开发
(四) 小规模生产、放大和根据现行药品生产质量管理规范(cGMP)生产
(五) 灌装-成品、放行检测、验证、稳定性检测和其他相关任务
(六) CMC研究报告文件,将使这些NIH项目的临床试验中的生物治疗剂能够进行监管备案和评价
B。 非临床服务包括但不限于:
(一) 在体外、体内或离体模型中的功效测试,包括使用患者来源的多能干细胞建模神经疾病,或在疾病的动物模型中,或在未处理动物中,或在离体组织或小外植体培养物中
(二) 吸收、分布、代谢和消除(ADME)研究
(三) 药代动力学(PK)和药效学(PD)表征
(四) 毒理学研究,包括但不限于单次给药和/或重复给药毒理学研究,和/或生殖毒理学和/或致癌性研究,和/或新生儿和青少年毒理学研究
(五) 非临床研究报告和文件,将使监管备案和评价生物疗法的临床试验,这些国家卫生研究院计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANE MURAL其他文献
JANE MURAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
- 批准号:
449429 - 财政年份:2020
- 资助金额:
$ 1.07万 - 项目类别:
Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
- 批准号:
20H03644 - 财政年份:2020
- 资助金额:
$ 1.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
- 批准号:
18K08466 - 财政年份:2018
- 资助金额:
$ 1.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
- 批准号:
24659444 - 财政年份:2012
- 资助金额:
$ 1.07万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
- 批准号:
17500284 - 财政年份:2005
- 资助金额:
$ 1.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
- 批准号:
07556128 - 财政年份:1995
- 资助金额:
$ 1.07万 - 项目类别:
Grant-in-Aid for Scientific Research (A)